Technologies

Will Putin Prevent Rebrikov from Attempting Heritable Genome Editing?

By Pete Shanks | 10.08.2019
Biopolitical Times
The Russian molecular biologist who wants to edit the genomes of human embryos is getting impatient with authorities who won't yet let him go ahead.
Policies

U.S. Government Plans to Collect DNA from Detained Immigrants

By Caitlin Dickerson, The New York Times | 10.02.2019

Aggregated News

The Department of Homeland Security said it would begin collecting genetic data on hundreds of thousands of immigrants in federal detention facilities.
Genomics

Despite Calls for a Moratorium, More ‘Three-Parent’ Babies Expected Soon

By Emily Mullin, One Zero | 09.16.2019

Aggregated News

At least 10 babies have been born to apparently infertile women as a result of a controversial in vitro fertilization...

Assisted Reproduction
a cartoon baby surrounded by dna

Sequencing projects will screen 200,000 newborns for disease genes

By Jocelyn Kaiser, Science | 12.12.2022

Aggregated News

Policies
purple cancer cells

Experimental CRISPR technique has promise against aggressive leukaemia

By Michael Le Page, New Scientist | 12.11.2022

Aggregated News

Human Genetic Modification
crispr

We Can Cure Disease by Editing a Person’s DNA. Why Aren’t We?

By Fyodor Urnov, The New York Times | 12.09.2022

Aggregated News

Human Genetic Modification

Some of Our Favorite 2022 Biopolitical Times Posts

By Pete Shanks | 12.09.2022
Biopolitical Times
Policies
He Jiankui at his panel in 2018

Any changes to law on human gene editing should be after public consultation

By Peter McKnight, Vancouver Sun | 12.08.2022

Aggregated News

Genomics
a dna double helix

They Trusted Their Prenatal Test. They Didn’t Know the Industry Is an Unregulated “Wild West.”

By Anna Clark, Adriana Gallardo, Jenny Deam and Mariam Elba, ProPublica | 12.06.2022

Aggregated News

U.S. Federal
neuron

A Promising Trial Targets a Genetic Risk for Alzheimer’s

By Gina Kolata, The New York Times | 12.05.2022

Aggregated News

Genomics
FDA logo

Do Verve's gene edits pass down to patients' children? The FDA wants to know

By Nick Paul Taylor, Fierce Biotech | 12.05.2022

Aggregated News

Genomics